🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

393,17 USD

Máx. histórico

447,03

14 días

Split 2:1 del 22/11/1999

Caída desde máximo

-12,05%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-10,08%

Cierre anterior

437,23

Rango de hoy

391,17 – 410,03

Volumen hoy

6.589.429

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
24,44 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 6 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,53%
Fecha de pago Importe por participación
16/11/2022 1,9400 USD
17/08/2022 1,9400 USD
16/05/2022 1,9400 USD
14/02/2022 1,9400 USD
15/11/2021 1,7600 USD
16/08/2021 1,7600 USD
14/05/2021 1,7600 USD
11/02/2021 1,7600 USD
13/11/2020 1,6000 USD
14/08/2020 1,6000 USD
15/05/2020 1,6000 USD
13/02/2020 1,6000 USD
14/11/2019 1,4500 USD
14/08/2019 1,4500 USD
16/05/2019 1,4500 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/08/2004 54,46 56,49 54,40 55,77 +2,59% 3,84% 7.692.200
13/08/2004 54,88 55,16 54,05 54,36 -0,86% 2,02% 5.056.500
12/08/2004 54,95 55,67 54,66 54,83 -0,67% 1,84% 7.266.400
11/08/2004 53,75 55,62 53,72 55,20 +2,41% 3,53% 9.057.200
10/08/2004 53,43 54,12 53,17 53,90 +1,26% 1,78% 7.973.200
09/08/2004 53,85 54,47 53,21 53,23 -1,06% 2,34% 6.517.600
06/08/2004 54,80 55,08 53,80 53,80 -2,36% 2,34% 9.439.100
05/08/2004 56,72 56,79 55,10 55,10 -2,56% 2,98% 6.976.300
04/08/2004 56,29 57,31 56,22 56,55 +0,35% 1,94% 6.965.600
03/08/2004 56,35 57,33 56,30 56,35 +0,07% 1,83% 8.332.900
02/08/2004 56,79 57,21 56,31 56,31 -1,00% 1,58% 8.186.500
30/07/2004 57,10 57,84 56,88 56,88 -0,21% 1,68% 8.401.800
29/07/2004 57,46 57,60 57,00 57,00 +0,00% 1,04% 7.898.700
28/07/2004 56,20 57,63 56,00 57,00 +1,95% 2,90% 12.890.600
27/07/2004 55,66 56,42 55,46 55,91 +0,74% 1,72% 10.324.300
26/07/2004 55,33 55,61 54,22 55,50 +0,25% 2,51% 9.155.200
23/07/2004 55,75 56,57 55,16 55,36 -1,32% 2,53% 8.466.500
22/07/2004 55,80 56,25 54,98 56,10 +0,45% 2,28% 9.275.400
21/07/2004 57,00 57,38 55,69 55,85 -2,02% 2,96% 9.486.100
20/07/2004 55,65 57,00 55,58 57,00 +2,50% 2,55% 7.403.200
19/07/2004 55,92 56,11 54,00 55,61 -0,22% 3,77% 9.395.800
16/07/2004 56,33 56,35 55,54 55,73 -0,48% 1,44% 9.409.800
15/07/2004 55,65 56,30 55,40 56,00 +0,90% 1,62% 11.525.600
14/07/2004 54,50 55,95 54,44 55,50 +1,80% 2,77% 10.697.600
13/07/2004 54,55 54,95 54,16 54,52 +1,00% 1,45% 6.548.700
12/07/2004 53,31 54,08 53,27 53,98 +0,69% 1,52% 6.232.500
09/07/2004 53,95 54,20 53,57 53,61 +0,54% 1,17% 6.122.700
08/07/2004 53,80 54,23 53,22 53,32 -1,06% 1,88% 5.940.100
07/07/2004 54,05 54,31 53,59 53,89 -0,26% 1,33% 6.486.600
06/07/2004 54,69 54,95 53,91 54,03 -2,12% 1,90% 7.892.000